Pfizer CEO, Albert Boula on Monday (January 10th) said a vaccine that targets the omicron variant will be ready in March, and the company has already begun manufacturing the doses.
Bourla told CNBC that the vaccine will also target the other variants that are circulating.
Photo via Today Online
He said it is still not clear whether or not an omicron vaccine is needed or how it would be used, but Pfizer will have some doses ready since some countries want it ready as soon as possible.
“The hope is that we will achieve something that will have way, way better protection particularly against infections, because the protection against the hospitalizations and the severe disease, it is reasonable right now, with the current vaccines as long as you are having let’s say, the third dose,” he said.
Real-world data from the United Kingdom has shown that Pfizer’s and Moderna’s vaccines are only about 10% effective at preventing symptomatic infection from Omicron 20 weeks after the second dose, according to study from the UK Health Security Agency.
Photo via UNICEF
However, the original two doses still provide good protection against severe illness.
Booster shots are up to 75% effective at preventing symptomatic infection, according to the study.
The vaccine works, guys and it prevents you from serious complications if you are infected with the COVID-19 virus.
Get yourself vaccinated, take care of yourself and the people around you. We’re all in this together!
By: Aishah Akashah Ahadiat
